Concert Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Concert Pharmaceuticals Ownership

Who owns Concert Pharmaceuticals?

Concert Pharmaceuticals is owned by Sun Pharmaceuticals Industries. It was acquired on January 19, 2023.

Was Concert Pharmaceuticals formerly PE-backed?

Yes. Concert Pharmaceuticals was formerly owned by 1 private investor.

Concert Pharmaceuticals Business Overview

Where is Concert Pharmaceuticals headquartered?

Concert Pharmaceuticals is headquartered in Lexington, Massachusetts.

How many employees does Concert Pharmaceuticals have?

Concert Pharmaceuticals has 48 employees.

What sector is Concert Pharmaceuticals in?

Concert Pharmaceuticals is a life science company.

When was Concert Pharmaceuticals founded?

Concert Pharmaceuticals was founded in 2006.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 201 acquisitions of life science companies in 2023, including 25 acquisitions by private equity firms, and 176 by strategics.

Concert Pharmaceuticals

Concert Pharmaceuticals, Inc.

99 Hayden Avenue, Suite 500,
Lexington, Massachusetts 02421
United States,
(781) 860-0045
www.concertpharma.com

Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing deuruxolitinib, a novel, deuterated, oral JAK1/2 inhibitor. The company has successfully completed two Phase 3 trials with deuruxolitinib in adults with Alopecia Areata, a serious autoimmune dermatological disease. It is also evaluating the use of deuruxolitinib in other indications and assessing a number of earlier-stage pipeline candidates. Concert Pharmaceuticals was founded in 2006 and is based in Lexington, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # 1 - - 1 - - 2
vol $160M $160M
  2

Most Recent M&A

Company Date Value Type
Concert Pharmaceuticals - CNS therapeutics 2022-03-11 - Divestiture
Lexington, Massachusetts
Concert Pharmaceuticals, Inc. - CTP-656 2017-03-06 160M USD Divestiture
Lexington, Massachusetts
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 2 (100%) 160M (100%)
Total - - 2 $160M

By Geo

State/Country Buy Value Sell Value
United States - - 2 160M
  Massachusetts - - 2 160M
Total - - 2 $160M

Deal Values

sell # Total
$100M to $1B 1 $160M
TOTAL $160M
Largest Concert Pharmaceuticals, Inc. - CTP-656
$160M (2017-03-06)

M&A Connections

Deals
Divested to
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.